Format

Send to

Choose Destination
Ther Drug Monit. 1997 Aug;19(4):375-81.

Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine.

Author information

1
St Bartholomew's Hospital, London, U.K.

Abstract

A critique of the current bioequivalence regulations is presented with reference to critical dose drugs. Using the development of a new cyclosporine formulation as an example, the deficiencies in current bioequivalence testing guidelines are examined and discussed. Based on the experience gained with cyclosporine, recommendations are made on how therapeutic equivalence, rather than just bioequivalence, should be established.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center